More than a half million babies in the United States - that's 1 in every 8 - are born premature each year.1

Making a Difference in the lives of prematurely born infants

These preemies are often at risk for a number of life-threatening complications including Necrotizing Enterocolitis (NEC) and Sepsis. One of the biggest hurdles these babies face is receiving enough calories and protein to develop and survive. By making the decision to donate your excess breast milk, you could have a significant impact on the lives of these infants and their families.

Milkbanking.net has been designed to aid healthy lactating women locate a donor milk bank. Donations of excess breast milk will be used to make nutritional therapies by Prolacta Bioscience® and sold to hospital Neonatal Intensive Care Units (NICUs). These products provide enhanced nutritional care required for low birth weight, premature and sometimes critically ill infants.

In conjunction with Prolacta Bioscience®, the goal of milkbanking.net is to provide an opportunity for all qualified donors across the contiguous United States to donate their excess milk by making the donation process convenient and confidential.



All milk banks within the Milkbanking.net system abide by HIPAA regulations and makes certain that all private information is kept secure.

1Centers for Disease Control and Prevention, http://www.cdc.gov/Features/PrematureBirth/

Featured Milk Bank
South Coast Midwifery

So. California, Nevada, and Arizona Residents Apply Online

South Coast Midwifery is home to Orange County's only accredited birth center. The founder and director, Lorri Walker, RNC, NP, CNM, is one of the Southern California's best known midwives. At SCM we embrace a partnership care with our clients, including them in all decision making.

In addition to offering a birthing alternative, we are a Prolacta Bioscience affiliated milk bank. The milk we collect is used by Prolacta Bioscience to make nutritional therapies for very premature infants. Recently, a clinical study was conducted using Prolacta's products in such institutions as Johns Hopkins and Yale. The results were published in the Journal of Pediatrics (www.jpeds.com) and the findings state there is a 2.6 fold reduction in Necrotizing entercolitis (NEC) and a 7.2 fold reduction in surgeries due to NEC when very premature infants are fed a 100% human based diet versus an essentially human milk based diet that also contained cow-milk formula. The products Prolacta Bioscience produces are the only ones on the market that allow for the full nutrition very premature infants require from a 100% human milk source.